Effects of Intraventricular Methotrexate on Neuronal Injury and Gene Expression in a Rat Model

Findings From an Exploratory Study

Ida M Moore, Carrie J Merkle, Howard Byrne, Adam Ross, Ashley M. Hawkins, Sara S. Ameli, David W Montgomery

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Central nervous system (CNS)-directed treatment for acute lymphoblastic leukemia, used to prevent disease recurrence in the brain, is essential for survival. Systemic and intrathecal methotrexate, commonly used for CNS-directed treatment, have been associated with cognitive problems during and after treatment. The cortex, hippocampus, and caudate putamen, important brain regions for learning and memory, may be involved in methotrexate-induced brain injury. Objectives of this study were to (1) quantify neuronal degeneration in selected regions of the cortex, hippocampus, and caudate putamen and (2) measure changes in the expression of genes with known roles in oxidant defense, apoptosis/inflammation, and protection from injury. Male Sprague Dawley rats were administered 2 or 4 mg/kg of methotrexate diluted in artificial cerebrospinal fluid (aCSF) or aCSF only into the left cerebral lateral ventricle. Gene expression changes were measured using customized reverse transcription (RT)2 polymerase chain reaction arrays. The greatest percentage of degenerating neurons in methotrexate-treated animals was in the medial region of the cortex; percentage of degenerating neurons in the dentate gyrus and cornu ammonis 3 regions of the hippocampus was also greater in rats treated with methotrexate compared to perfusion and vehicle controls. There was a greater percentage of degenerating neurons in the inferior cortex of control versus methotrexate-treated animals. Eight genes involved in protection from injury, oxidant defense, and apoptosis/inflammation were significantly downregulated in different brain regions of methotrexate-treated rats. To our knowledge, this is the first study to investigate methotrexate-induced injury in selected brain regions and gene expression changes using a rat model of intraventricular drug administration.

Original languageEnglish (US)
Pages (from-to)505-514
Number of pages10
JournalBiological Research for Nursing
Volume18
Issue number5
DOIs
StatePublished - Oct 1 2016

Fingerprint

Methotrexate
Gene Expression
Wounds and Injuries
Hippocampus
Putamen
Brain
Neurons
Oxidants
Cerebrospinal Fluid
Central Nervous System
Apoptosis
Inflammation
Cerebral Ventricles
Lateral Ventricles
Dentate Gyrus
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Brain Injuries
Reverse Transcription
Sprague Dawley Rats
Down-Regulation

Keywords

  • brain injury
  • gene expression
  • laser capture microdissection
  • methotrexate
  • neuronal degeneration
  • rat model

ASJC Scopus subject areas

  • Research and Theory

Cite this

Effects of Intraventricular Methotrexate on Neuronal Injury and Gene Expression in a Rat Model : Findings From an Exploratory Study. / Moore, Ida M; Merkle, Carrie J; Byrne, Howard; Ross, Adam; Hawkins, Ashley M.; Ameli, Sara S.; Montgomery, David W.

In: Biological Research for Nursing, Vol. 18, No. 5, 01.10.2016, p. 505-514.

Research output: Contribution to journalArticle

@article{1f093530f19a4fe08d7d887c861fc3c2,
title = "Effects of Intraventricular Methotrexate on Neuronal Injury and Gene Expression in a Rat Model: Findings From an Exploratory Study",
abstract = "Central nervous system (CNS)-directed treatment for acute lymphoblastic leukemia, used to prevent disease recurrence in the brain, is essential for survival. Systemic and intrathecal methotrexate, commonly used for CNS-directed treatment, have been associated with cognitive problems during and after treatment. The cortex, hippocampus, and caudate putamen, important brain regions for learning and memory, may be involved in methotrexate-induced brain injury. Objectives of this study were to (1) quantify neuronal degeneration in selected regions of the cortex, hippocampus, and caudate putamen and (2) measure changes in the expression of genes with known roles in oxidant defense, apoptosis/inflammation, and protection from injury. Male Sprague Dawley rats were administered 2 or 4 mg/kg of methotrexate diluted in artificial cerebrospinal fluid (aCSF) or aCSF only into the left cerebral lateral ventricle. Gene expression changes were measured using customized reverse transcription (RT)2 polymerase chain reaction arrays. The greatest percentage of degenerating neurons in methotrexate-treated animals was in the medial region of the cortex; percentage of degenerating neurons in the dentate gyrus and cornu ammonis 3 regions of the hippocampus was also greater in rats treated with methotrexate compared to perfusion and vehicle controls. There was a greater percentage of degenerating neurons in the inferior cortex of control versus methotrexate-treated animals. Eight genes involved in protection from injury, oxidant defense, and apoptosis/inflammation were significantly downregulated in different brain regions of methotrexate-treated rats. To our knowledge, this is the first study to investigate methotrexate-induced injury in selected brain regions and gene expression changes using a rat model of intraventricular drug administration.",
keywords = "brain injury, gene expression, laser capture microdissection, methotrexate, neuronal degeneration, rat model",
author = "Moore, {Ida M} and Merkle, {Carrie J} and Howard Byrne and Adam Ross and Hawkins, {Ashley M.} and Ameli, {Sara S.} and Montgomery, {David W}",
year = "2016",
month = "10",
day = "1",
doi = "10.1177/1099800416644780",
language = "English (US)",
volume = "18",
pages = "505--514",
journal = "Biological Research for Nursing",
issn = "1099-8004",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Effects of Intraventricular Methotrexate on Neuronal Injury and Gene Expression in a Rat Model

T2 - Findings From an Exploratory Study

AU - Moore, Ida M

AU - Merkle, Carrie J

AU - Byrne, Howard

AU - Ross, Adam

AU - Hawkins, Ashley M.

AU - Ameli, Sara S.

AU - Montgomery, David W

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Central nervous system (CNS)-directed treatment for acute lymphoblastic leukemia, used to prevent disease recurrence in the brain, is essential for survival. Systemic and intrathecal methotrexate, commonly used for CNS-directed treatment, have been associated with cognitive problems during and after treatment. The cortex, hippocampus, and caudate putamen, important brain regions for learning and memory, may be involved in methotrexate-induced brain injury. Objectives of this study were to (1) quantify neuronal degeneration in selected regions of the cortex, hippocampus, and caudate putamen and (2) measure changes in the expression of genes with known roles in oxidant defense, apoptosis/inflammation, and protection from injury. Male Sprague Dawley rats were administered 2 or 4 mg/kg of methotrexate diluted in artificial cerebrospinal fluid (aCSF) or aCSF only into the left cerebral lateral ventricle. Gene expression changes were measured using customized reverse transcription (RT)2 polymerase chain reaction arrays. The greatest percentage of degenerating neurons in methotrexate-treated animals was in the medial region of the cortex; percentage of degenerating neurons in the dentate gyrus and cornu ammonis 3 regions of the hippocampus was also greater in rats treated with methotrexate compared to perfusion and vehicle controls. There was a greater percentage of degenerating neurons in the inferior cortex of control versus methotrexate-treated animals. Eight genes involved in protection from injury, oxidant defense, and apoptosis/inflammation were significantly downregulated in different brain regions of methotrexate-treated rats. To our knowledge, this is the first study to investigate methotrexate-induced injury in selected brain regions and gene expression changes using a rat model of intraventricular drug administration.

AB - Central nervous system (CNS)-directed treatment for acute lymphoblastic leukemia, used to prevent disease recurrence in the brain, is essential for survival. Systemic and intrathecal methotrexate, commonly used for CNS-directed treatment, have been associated with cognitive problems during and after treatment. The cortex, hippocampus, and caudate putamen, important brain regions for learning and memory, may be involved in methotrexate-induced brain injury. Objectives of this study were to (1) quantify neuronal degeneration in selected regions of the cortex, hippocampus, and caudate putamen and (2) measure changes in the expression of genes with known roles in oxidant defense, apoptosis/inflammation, and protection from injury. Male Sprague Dawley rats were administered 2 or 4 mg/kg of methotrexate diluted in artificial cerebrospinal fluid (aCSF) or aCSF only into the left cerebral lateral ventricle. Gene expression changes were measured using customized reverse transcription (RT)2 polymerase chain reaction arrays. The greatest percentage of degenerating neurons in methotrexate-treated animals was in the medial region of the cortex; percentage of degenerating neurons in the dentate gyrus and cornu ammonis 3 regions of the hippocampus was also greater in rats treated with methotrexate compared to perfusion and vehicle controls. There was a greater percentage of degenerating neurons in the inferior cortex of control versus methotrexate-treated animals. Eight genes involved in protection from injury, oxidant defense, and apoptosis/inflammation were significantly downregulated in different brain regions of methotrexate-treated rats. To our knowledge, this is the first study to investigate methotrexate-induced injury in selected brain regions and gene expression changes using a rat model of intraventricular drug administration.

KW - brain injury

KW - gene expression

KW - laser capture microdissection

KW - methotrexate

KW - neuronal degeneration

KW - rat model

UR - http://www.scopus.com/inward/record.url?scp=84987704731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987704731&partnerID=8YFLogxK

U2 - 10.1177/1099800416644780

DO - 10.1177/1099800416644780

M3 - Article

VL - 18

SP - 505

EP - 514

JO - Biological Research for Nursing

JF - Biological Research for Nursing

SN - 1099-8004

IS - 5

ER -